Publication | Closed Access

Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study

Neuro-oncologyRetrospective Cohort StudyGliomaMedicineEpigenetic ChangeSignificant Survival BenefitPathologyCancer GenomicsHigh-grade GliomasCell BiologyCancer GeneticsCancer TreatmentOncologyRadiation OncologyEpigenetics